Get started
Author

Л. Н. Прахова

Observed names: L N Prakhova, L. N. Prakhova, L. Prakhova, L.N. Prakhova, Lidiia Prakhova, LidiiaN Prakhova, Прахова Л.Н.
ORCID: 0000-0002-4776-2999
Observed ORCID: 0000-0002-4776-2999
OpenAlex ID: A5043236026
SNCA variants and alpha-synuclein level in CD45+ blood cells in Parkinson’s disease
2018 · A. Emelyanov, D. Kulabukhova, et al. · Journal of the Neurological Sciences · 23
Results of a phase 1 clinical study of anti-CD20 monoclonal antibody (BCD-132): pharmacokinetics, pharmacodynamics and safety
2019 · O.V. Boyko, A.N. Boyko, et al. · S S Korsakov Journal of Neurology and Psychiatry · 22
Efficacy and safety of antiCD20 monoclonal antibody divozilimab during 48-week treatment of multiple sclerosis patients in randomized double-blind placebo-controlled clinical trial BCD-132-4/MIRANTIBUS
2023 · A.N. Boyko, V.M. Alifirova, et al. · S S Korsakov Journal of Neurology and Psychiatry · 14
Characteristics of neurological and cognitive status in patients with multiple sclerosis in relation to the location and volumes of demyelination foci and the severity of brain atrophy
2008 · K. K. Mineev, L. N. Prakhova, et al. · Neuroscience and Behavioral Physiology · 14
Long-term efficacy and safety of divozilimab during 2-year treatment of multiple sclerosis patients in randomized double-blind placebo-controlled clinical trial BCD-132-4/MIRANTIBUS
2024 · A.N. Boyko, V.M. Alifirova, et al. · S S Korsakov Journal of Neurology and Psychiatry · 13
PDF
Efficacy and safety of divozilimab during 24-week treatment of multiple sclerosis patients in randomized double-blind placebo-controlled clinical trial BCD-132-2
2023 · A.N. Boyko, V.M. Alifirova, et al. · S S Korsakov Journal of Neurology and Psychiatry · 13
Successful treatment of human immunodeficiency virus-associated highly active antiretroviral therapy-resistant vacuolar myelopathy with intravenous immunoglobulin
2019 · LidiiaN Prakhova, AleksandrG Ilves, et al. · Annals of Indian Academy of Neurology · 8
High-dose immunosuppressive therapy with autologous hematopoietic stem cell transplantation in multiple sclerosis: preliminary clinical results of approbation of the method
2022 · A. Yu. Polushin, Yu. R. Zalyalov, et al. · Russian neurological Journal · 7
Local experience of IL-6 pathway inhibition with satralizumab for patients with neuromyelitis optica spectrum disorder
2022 · L.N. Prakhova, V.S. Krasnov, et al. · S S Korsakov Journal of Neurology and Psychiatry · 5
[Changes of cerebral glucose metabolism in patients with multiple sclerosis and their role in formation of the clinical picture and progression of the disease].
2003 · A G Il'ves, L N Prakhova, et al. · PubMed · 5
Current view on the diagnosis and treatment of neuromyelitis optica spectrum disorders exacerbations
2022 · V. S. Krasnov, L. N. Prakhova, et al. · Neurology neuropsychiatry Psychosomatics · 4
PDF
Effect of Neurodegenerative Changes in the Brain on the Formation of the Disease Clinical Picture in Patients With Multiple Sclerosis
2013 · L. N. Prakhova, Ye. P. Magonov, et al. · Bulletin of Siberian Medicine · 4
PDF
The Role of Changes in Glucose Metabolism in the Brain in the Formation of Cognitive Impairments in Patients with Remitting and Secondary-Progressive Multiple Sclerosis
2013 · G. G. Shkil’nyuk, A. G. Il’ves, et al. · Neuroscience and Behavioral Physiology · 4
[Intrathecal immunoglobulin production in the diagnosis and differential diagnosis of multiple sclerosis].
2012 · N A Totolian, A A Gotovchikov, et al. · PubMed · 4
Neuropsychological and morphometric biomarkers of poor prognosis in patients with mild cognitive impairment
2022 · A. A. Smirnova, L. N. Prakhova, et al. · Russian neurological Journal · 3
Monoclonal gammopathy of undetermined significance (MGUS) manifestation in CNS: a regular or chance occurrence?
2021 · Lidiia Prakhova, Valeriy Lebedev, et al. · BMJ Case Reports · 3
Diagnostic Value of Short and Long Echo Time in 1H-MRS for Patients with Multiple Sclerosis
2017 · A. A. Bogdan, G. V. Kataeva, et al. · Applied Magnetic Resonance · 3
Regional metabolic changes of supraventricular tissue in patients with relapsing-remitting and secondary-progressive multiple sclerosis
2015 · A. A. Bogdan, A. G. Ilves, et al. · S S Korsakov Journal of Neurology and Psychiatry · 3
[Clinical and radiological (PET, MRI) correlations depending on disease progression in patients with multiple sclerosis].
2006 · A G Il'ves, L N Prakhova, et al. · PubMed · 3
Capabilities of positron emission tomography to study mechanisms of multiple sclerosis: own data and literature
2016 · I. D. Stolyarov, A. M. Petrov, et al. · S S Korsakov Journal of Neurology and Psychiatry · 2
[PET-patterns of cognitive impairment in patients with multiple sclerosis].
2013 · G G Shkil'niuk, A G Il'ves, et al. · PubMed · 2
Assessment of biomechanical parameters of feet in patients with multiple sclerosis during walking
2023 · A. D. Dorokhov, E. V. Ivashkova, et al. · Russian neurological Journal · 1
PDF
Difficulties in the differential diagnosis of multiple sclerosis and Susak syndrome
2021 · Zh. I. Savintseva, A. G. Ilves, et al. · Diagnostic radiology and radiotherapy · 1
PDF
ЭКСПРЕССИЯ CD56 ЦИТОТОКСИЧЕСКИМИ Т-ЛИМФОЦИТАМИ ПЕРИФЕРИЧЕСКОЙ КРОВИ ПРИ РАССЕЯННОМ СКЛЕРОЗЕ, "Российский иммунологический журнал"
2018 · Игорь Владимирович Кудрявцев, А.Г. Ильвес, et al. · Russian Journal of Immunology · 1
Neuroprotection therapy of multiple sclerosis with high doses of ethylmethylhydroxypyridine succinate
2016 · L. N. Prakhova, A. G. Ilves, et al. · S S Korsakov Journal of Neurology and Psychiatry · 1
Works count: 52
Citation count: 171
H-index: 7
I10-index: 6
Year
Topic
Type